| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Sr. VP & CMO
1 company
Scott T. Rottinghaus is Chief Medical Officer at ENTA. Scott T. Rottinghaus's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $247K at current prices.
Our model assigns Scott T. Rottinghaus a middling insider score of 69/100, based on 6 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +20.6%.
The ENTA filings lean toward selling, a net 14,143 shares.
Scott T. Rottinghaus has 15 Form 4 filings on record from August 2022 to August 2026, all as Chief Medical Officer at Enanta Pharmaceuticals (ENTA), 2022–2026.
The 25 reported transactions were 7 tax withholdings, 6 stock awards, 6 open-market sales and 5 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 4 sales worth about $214K.
The largest open-market sale was 11,945 shares of ENTA at an average $15.97 on July 15, 2024, about $191K. Twelve months later ENTA was down 60%.
2 of the 4 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 2 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | ENTA Enanta Pharmaceuticals Inc | Chief Medical Officer | Sell | 798 | $14.23 | $11,355.54 | -3.5% | -5.8% | - | |
| Dec 6, 2024 | ENTA Enanta Pharmaceuticals Inc | Chief Medical Officer | Sell10b5-1 | 866 | $8.06 | $6,979.96 | -4.6% | -10.3% | +82.5% | |
| Jul 15, 2024 | ENTA Enanta Pharmaceuticals Inc | Chief Medical Officer | Sale+OE10b5-1 | 11,945 | $15.97 | $190,746.77 | -35.5% | -31.6% | -60.2% | |
| Dec 5, 2023 | ENTA Enanta Pharmaceuticals Inc | Sr. VP & CMO | Sell | 534 | $9.63 | $5,142.42 | -2.0% | +65.3% | -9.9% |